<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT03157934</url>
  </required_header>
  <id_info>
    <org_study_id>FAST</org_study_id>
    <nct_id>NCT03157934</nct_id>
  </id_info>
  <brief_title>Schlaganfallkonsortium Rhein-Neckar (Stroke Consortium Rhine-Neckar)</brief_title>
  <acronym>FAST</acronym>
  <official_title>Schlaganfallkonsortium Rhein-Neckar (Stroke Consortium Rhine-Neckar)</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>University Hospital Heidelberg</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>Dietmar Hopp Stiftung</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>University Hospital Heidelberg</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      FAST is an investigator-initiated multicenter study embedded in a German multistate acute&#xD;
      stroke network. The main objectives of the FAST study are to improve outcomes and quality of&#xD;
      care for stroke patients, to quantify the number of patients in need of thrombectomy within&#xD;
      an integrated stroke network, to study the best way of delivering and performing thrombectomy&#xD;
      and to investigate the best model of pre-hospital selection and referral for stroke patients.&#xD;
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Since 2015, mechanical thrombectomy in patients with large vessel occlusion has become an&#xD;
      evidence based highly efficient treatment. In contrast to thrombolysis, thrombectomy can only&#xD;
      be delivered by qualified interventionalists at comprehensive stroke centers. Thus, the&#xD;
      implementation of thrombectomy into clinical practice remains a challenge. The investigators&#xD;
      aim to establish a population based approach within a patient registry in a federal state&#xD;
      overarching regional stroke network covering over 4 million inhabitants and integrating&#xD;
      approximately 30 hospitals with different levels of expertise. The registry will include data&#xD;
      from all acute ischemic stroke patients - approx. 12.000 patients p.a - within the network.&#xD;
      The investigators plan to establish a central multi-interface platform integrating clinical&#xD;
      data from the prehospital, intrahospital and rehabilitation phase including mandatory quality&#xD;
      assurance, neurological and neuroradiological treatment and outcome data. The registry will&#xD;
      allow addressing important questions, such as how many patients are candidates for&#xD;
      thrombectomy, how many resources are needed to meet that demand and how treatment procedures&#xD;
      and times can be improved. The overarching aim is to deliver high quality stroke care to&#xD;
      every patient in the region.&#xD;
    </textblock>
  </detailed_description>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">October 26, 2017</start_date>
  <completion_date type="Anticipated">March 2022</completion_date>
  <primary_completion_date type="Anticipated">December 2021</primary_completion_date>
  <study_type>Observational [Patient Registry]</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Other</observational_model>
    <time_perspective>Prospective</time_perspective>
  </study_design_info>
  <target_duration>3 Months</target_duration>
  <primary_outcome>
    <measure>Functional outcome</measure>
    <time_frame>3 months after intevention</time_frame>
    <description>Functional outcome according to the modified Rankin Scale (mRS)</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Number of patients receiving acute recanalisation therapies of all referrals</measure>
    <time_frame>24 h after stroke onset</time_frame>
    <description>Number of patients receiving thrombolysis and/or thrombectomy of all patients included in to the Network via the database.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Referral rates</measure>
    <time_frame>Stroke onset to discharge from acute hospital; through study completion, an average of 2 years</time_frame>
    <description>Referral rates by stroke service level (i.e. type of treatment center)</description>
  </secondary_outcome>
  <number_of_groups>3</number_of_groups>
  <enrollment type="Anticipated">12000</enrollment>
  <condition>Ischemic Stroke</condition>
  <condition>Vascular Diseases</condition>
  <condition>Cardiovascular Diseases</condition>
  <arm_group>
    <arm_group_label>Primary CSC admission</arm_group_label>
    <description>Patients with primary admission to endovascular-ready hospital (comprehensive stroke center)</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Primary non-CSC SU admission</arm_group_label>
    <description>Patients with primary admission to non-endovascular-ready hospital with (regional/local) stroke unit</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Non-acute stroke hospital admission</arm_group_label>
    <description>Patients with primary admission to non-acute stroke-ready hospital</description>
  </arm_group>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>not applicable (observational study)</intervention_name>
    <description>Observational study without study related intervention</description>
    <arm_group_label>Non-acute stroke hospital admission</arm_group_label>
    <arm_group_label>Primary CSC admission</arm_group_label>
    <arm_group_label>Primary non-CSC SU admission</arm_group_label>
  </intervention>
  <eligibility>
    <study_pop>
      <textblock>
        Acute stroke patients admitted to one of the hospitals of the Stroke Consortium&#xD;
        Rhein-Neckar (FAST)&#xD;
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  18 years or older&#xD;
&#xD;
          -  Patients with ischemic stroke who are admitted to one of the hospitals of the Stroke&#xD;
             Consortium Rhein-Neckar (FAST)&#xD;
&#xD;
          -  informed consent&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  no informed consent&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Wolfgang Wick, Prof. Dr.</last_name>
    <role>Principal Investigator</role>
    <affiliation>University Hospital Heidelberg</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Loraine Busetto, Dr.</last_name>
    <phone>+49622156</phone>
    <phone_ext>34149</phone_ext>
    <email>loraine.busetto@med.uni-heidelberg.de</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Maja Zenz, PhD</last_name>
    <phone>+49622156</phone>
    <phone_ext>34391</phone_ext>
    <email>maja.zenz@med.uni-heidelberg.de</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>Heidelberg University Hospital</name>
      <address>
        <city>Heidelberg</city>
        <zip>69120</zip>
        <country>Germany</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Loraine Busetto, Dr.</last_name>
      <phone>+49622156</phone>
      <phone_ext>34149</phone_ext>
      <email>loraine.busetto@med.uni-heidelberg.de</email>
    </contact>
  </location>
  <location_countries>
    <country>Germany</country>
  </location_countries>
  <link>
    <url>https://www.researchgate.net/project/FAST-STROKE-CONSORTIUM-RHINE-NECKAR</url>
    <description>FAST on ResearchGate</description>
  </link>
  <link>
    <url>https://twitter.com/FAST_Heidelberg</url>
    <description>FAST on Twitter</description>
  </link>
  <verification_date>November 2020</verification_date>
  <study_first_submitted>May 16, 2017</study_first_submitted>
  <study_first_submitted_qc>May 16, 2017</study_first_submitted_qc>
  <study_first_posted type="Actual">May 17, 2017</study_first_posted>
  <last_update_submitted>November 4, 2020</last_update_submitted>
  <last_update_submitted_qc>November 4, 2020</last_update_submitted_qc>
  <last_update_posted type="Actual">November 5, 2020</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>University Hospital Heidelberg</investigator_affiliation>
    <investigator_full_name>Prof. Dr. Wolfgang Wick</investigator_full_name>
    <investigator_title>Chairman of the Neurologic Clinic</investigator_title>
  </responsible_party>
  <keyword>stroke network</keyword>
  <keyword>acute stroke care</keyword>
  <keyword>emergency medical services</keyword>
  <keyword>integrated care</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Stroke</mesh_term>
    <mesh_term>Ischemic Stroke</mesh_term>
    <mesh_term>Cardiovascular Diseases</mesh_term>
    <mesh_term>Vascular Diseases</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>Undecided</sharing_ipd>
    <ipd_description>Subject to approval by ethics committee</ipd_description>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

